方案治疗晚期乳腺癌临床观察[J].现代中西医结合杂志,2016,25(30):3370-3372.
[12]Stockler MR,Harvey VJ,Francis PA,et al.Capecitabine versus classical cyclophosphamide,methotrexate,and fluoro?鄄uracil as first line chemotherapy for advanced breast cancer[J].J Clin Oncol,2011,29(34):4498-4504.
[13]吕红琼,谢玲,倪明立,等.吉西他滨联合卡培他滨治疗复发转移乳腺癌的疗效观察[J].中国癌症防治杂志,2016, 8(4):249-251.
[14]Huang H,Jiang Z,Wang T,et al.Single-agent capecitabine main-tenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer[J].Anti-cancer Drugs,2012,23(7):718-723.
[15]应文敏,郑兰飞,胡可,等.卡培他滨联合多西他赛治疗乳腺癌脑转移的效果观察[J].中国现代医生,2016,54(31):84-86.
[16]张妮,周晓明.曲妥珠单抗联合阿霉素脂质体治疗HER-2过度表达乳腺癌的临床疗效分析[J].中国医院药学杂志,2015,35(23):2126-2128.
(收稿日期:2017-04-10 本文编辑:祁海文)